[18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)
Clinical trial NCT07723651 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07723651
- Sponsor
- Washington University School of Medicine
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2032-03-31
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.